We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen Takes Sensipar Dispute to Appellate Court
A dispute between Amgen and generics maker Cipla is headed to appellate court after a federal judge turned aside Amgen’s effort to get Cipla to stop making generics of the blockbuster Sensipar while the two companies litigate over rights.